Scan to Download
One power score. Smarter investment decisions
Citius Oncology Inc
CTOR1.760USD
+0.010+0.57%
Close 09/19, 16:00（ET）Quotes delayed by 15 min
USD0.000After-hours (ET)
125.93MMarket Cap
LossP/E TTM
Citius Oncology Inc
1.760
+0.010+0.57%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q2
FY2023Q4
FY2023Q3
Total equity
Cash, cash equivalents and short-term investments
--112.00
--112.00
--112.00
--112.00
--0.00
--0.00
--0.00
- Cash and cash equivalents
--112.00
--112.00
--112.00
--112.00
--0.00
--0.00
--0.00
Inventory
--17.21M
--15.34M
--14.38M
--8.27M
----
----
----
Prepaid expenses
--1.10M
-69.69%2.70M
--2.70M
-65.09%2.70M
--8.91M
--7.73M
--7.73M
Other current assets
--0.00
--0.00
----
----
----
----
----
Total current assets
--18.31M
102.53%18.04M
--17.08M
41.81%10.97M
--8.91M
--7.73M
--7.73M
Non-current assets
Goodwill and other intangible assets
--73.40M
83.50%73.40M
--73.40M
83.50%73.40M
--40.00M
--40.00M
--40.00M
Other non-current assets
--0.00
--0.00
----
----
----
----
----
Total non-current assets
--73.40M
83.50%73.40M
--73.40M
83.50%73.40M
--40.00M
--40.00M
--40.00M
Total assets
--91.71M
86.97%91.44M
--90.48M
76.74%84.37M
--48.91M
--47.73M
--47.73M
Liabilities
Current liabilities
-Other payables
--35.86M
22.96%33.34M
--31.30M
48.67%28.99M
--27.12M
--19.50M
--16.19M
Accrued expenses
--8.46M
--8.72M
--6.23M
-100.00%0.00
--0.00
--259.07K
--511.40K
Other current liabilities
--35.86M
22.96%33.34M
--31.30M
48.67%28.99M
--27.12M
--19.50M
--16.19M
Total current liabilities
--52.99M
80.09%49.74M
--43.40M
55.37%32.70M
--27.62M
--21.05M
--17.97M
Non-current liabilities
Long-term debt and lease liabilities
--3.80M
--3.80M
--3.80M
--3.80M
--0.00
--0.00
--0.00
-Long-term debt
--3.80M
--3.80M
--3.80M
--3.80M
----
----
----
Other non-current liabilities
----
----
----
---1.00
----
----
----
Total non-current liabilities
--6.32M
320.60%6.06M
--5.79M
379.87%5.53M
--1.44M
--1.15M
--1.01M
Total liabilities
--59.31M
92.00%55.80M
--49.19M
72.21%38.23M
--29.06M
--22.20M
--18.98M
Shareholders' equity
Common equity
--91.44M
87.88%89.32M
--87.23M
95.62%85.42M
--47.54M
--43.67M
--41.70M
Retained earnings
---59.04M
-93.82%-53.67M
---45.94M
-116.65%-39.28M
---27.69M
---18.13M
---12.94M
Capital reserves
--91.43M
87.89%89.31M
--87.22M
95.63%85.41M
--47.53M
--43.66M
--41.69M
Total equity
--32.40M
79.59%35.64M
--41.29M
80.69%46.14M
--19.85M
--25.54M
--28.76M
Currency unit
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
